• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      India Ranbaxy Q3 profit jumps, beats forecast

      Posted Atwww.Reuters.com

      Ranbaxy, controlled by Japan's Daiichi Sankyo (4568.T), said consolidated net profit stood at 3.08 billion rupees ($69.5 million) for the fiscal third-quarter ended September. This compared with 1.15 billion rupees reported a year earlier.

      A Reuters poll had forecast net profit of 1.4 billion rupees for the firm, which is reporting its first quarter of results under a new chief executive who took over in August. Last month, rival Dr Reddy's Laboratories Ltd (REDY.BO) topped estimates with a 32-percent jump in quarterly profit boosted by strong sales in the domestic market. [ID:nSGE69O02L].

      Ranbaxy shares, which the market values at $5.7 billion, have risen about 17 percent so far this year, underperforming the 34-percent rise in the sector index .BSEHC and the main index's 19.5 percent gain. ($1= 44.3 rupees) (Reporting by Prashant Mehra; editing by Malini Menon)

      Nov 15, 2010


       

      Share this Article!

    Back to top^